Every story as it publishes, newest first.
Five Nasdaq stocks share the same ex-dividend deadline this week, but they are not all worth buying for the same reason, and at least one comes with a warning flag that most income investors…
Tesla just posted record deliveries while its operating income collapsed and free cash flow went negative, yet BYD keeps selling more electrified vehicles than any company on earth. Which bet actually wins the next…
While seasoned hedge fund managers were quietly offloading their Microsoft shares, Bill Ackman made one of his biggest bets in years going the opposite direction, and he funded it by selling a stock that…
SpaceX just posted one of the most impressive earnings reports in recent memory, and the stock is getting crushed anyway. Two converging forces are threatening to swamp even the strongest bull case, and one…
AMD just posted a record quarter and the stock is tanking anyway, while NVIDIA is surging on a surprise deal that doubles as a direct shot at AMD's biggest ambitions.
A paid-off home and a few thousand dollars in overdue property taxes should not be a catastrophic combination, but in Illinois they could cost a retiree every dollar of equity she spent decades building.
UnitedHealth crushed Q2 estimates and doubled its buyback, yet the stock has pulled back since the report. Whether that dip signals a buying opportunity or a warning sign depends on one number management cannot…
AbbVie's blockbuster drugs are surging while a major acquisition looms, but a trailing P/E of 71 and one model pricing the stock nearly $50 below current levels raises a real question about whether the…
Seth Klarman spent four decades building a reputation for buying almost nothing, so when Baupost quietly planted a nine-figure flag in a payment network last quarter, the choice of which rail he picked over…
Eli Lilly just posted one of the most impressive quarters in pharmaceutical history, but the drug powering those numbers may not be what defines the company a decade from now. A billion-dollar bet on…
SpaceX delivered a blockbuster revenue beat in its first public earnings report, yet shares are cratering while every other space stock barely flinches. What spooked investors has nothing to do with rockets and everything…
Roblox stock shed more than 70% of its value in a year, yet Wall Street analysts and company insiders are moving in the opposite direction from the selloff. Here is what the conflicting signals…
XRP has shed 42% since January while rate hikes loom, crypto sentiment sours, and a key piece of legislation stalls in the Senate. Three things need to break the right way before the coin…
Gasoline prices are punishing drivers at the pump while a handful of companies are posting the most profitable quarters in their histories, and the structural reason this keeps happening has nothing to do with…
Credo Technology tripled revenue and crushed earnings, yet the stock sits 10% below its highs while analysts debate whether a specific price target by 2030 is ambition or fantasy. Three things have to break…
